Effect of flavonoids on daunorubicin-induced toxicity in H9c2 cardiomyoblasts

Phytotherapy Research

Volumn 23, Issue 1, 2009, Pages 136-139

  Mojžišová, Gabriela ^a   Šarišský, Marek ^a   Mirossay, Ladislav ^a   Martinka, Peter ^b   Mojžiš, Ján ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Apoptosis; Cardiotoxicity; Daunorubicin; Flavonoids; Trolox

Indexed keywords

DAUNORUBICIN; FLAVONOID; NARINGENIN; PYCNOGENOL; QUERCETIN; TROLOX C;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARDIOTOXICITY; CELL LINE; CELL PROTECTION; CELL SURVIVAL; CYTOTOXICITY; H9C2 CELL; HEART PROTECTION; INCUBATION TIME; MYOBLAST; NONHUMAN; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELLS, CULTURED; CHROMANS; DAUNORUBICIN; FLAVANONES; FLAVONOIDS; MYOCYTES, CARDIAC; QUERCETIN; RATS;

EID: 58149504282     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2566     Document Type: Article

References (12)

1. Ejlertsen B, Mouridsen HT, Langkjer ST, Andersen J, Sjostrom J, Kjaer M. 2004. Scandinavian Breast Group Trial (SBG9403). Phase III study of intravenous vinorelbine in combination with epirubicin versus epirubicin alone in patients with advanced breast cancer: a Scandinavian Breast Group Trial (SBG9403). J Clin Oncol 22: 2313-2320.
2. 2+-dependent manner. J Cell Mol Med 10: 216-224.
3. Kaiserová H, Šimůnek T, van der Vijgh WJ, Bast A, Kvasničková E. 2007. Flavonoids as protectors against doxorubicin cardiotoxicity: role of iron chelation, anti-oxidant activity and inhibition of carbonyl reductase. Biochim Biophys Acta 1772: 1065-1074.
4. Kim MS, Kwon DY, Cho HJ, Lee MS. 2006. Protective effects of Korean herbal remedy against oxidative stress in cardiomyocytes. Phytother Res 20: 235-236.
5. Kimes BW, Brandt BL. 1976. Properties of a clonal muscle cell line from rat heart. Exp Cell Res 98: 367-381.
6. Melzig MF, Loose R, Schönherr G. 1997. Effect of flavonoids on daunomycin-induced toxicity in cultivated endothelial cells. Pharmazie 52: 793-796.
7. Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. 2004. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 56: 185-229.
8. Mojžišová G, Mirossay L, Kučerová D, Kyselovič J, Miroššay A, Mojžiš J. 2006. Protective effect of selected flavonoids on in vitro daunorubicin-induced cardiotoxicity. Phytother Res 20: 110-114.
9. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 65: 55-63.
10. Park C, So HS, Shin SH et al. 2007. The water extract of Omija protects H9c2 cardiomyoblast cells from hydrogen peroxide through prevention of mitochondrial dysfunction and activation of caspases pathway. Phytother Res 21: 81-88.
11. Van Acker FAA, Van Acker SABE, Kramer K, Haenen GRMM, Bast A, Van Der Vijgh WJF. 2000. 7-Monohydroxyethylrutoside protects against chronic doxorubicin-induced cardiotoxicity when administered only once per week. Clin Can Res 6: 1337-1341.
12. Zucchi R, Danesi R. 2003. Cardiac toxicity of antineoplastic anthracyclines. Curr Med Chem Anticancer Agents 3: 151-171.